Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.31 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42467 | 0.97 | TP53 (0.39) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL8985021 | 0.93 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| Hydrochloric Acid SCHEMBL4680206 | 0.93 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL8386961 | 0.93 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL8985028 | 0.93 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL672963 | 0.93 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL673528 | 0.93 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| SCHEMBL638833 | 0.93 | TP53 (0.37) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| Hydrazine SCHEMBL16039959 | 0.90 | TP53 (0.35) | TP53P2RX4P2RX1P2RX3P2RX7 | |
| Cyclohexane SCHEMBL3905056 | 0.88 | ADH1B (0.34) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 422 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3969490-B1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS | BRIDGESTONE CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12565546-B2 | Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer | LG CHEM, LTD. (KR) | 2026-03-03 | — | — | US | disclosed |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4653477-A1 | CONJUGATED DIENE-BASED POLYMER AND RUBBER COMPOSITION | LG CHEM, LTD. (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-12410263-B2 | Modified high-Cis polybutadiene polymer, related methods and rubber compositions | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| EP-4032921-B1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | LG CHEMICAL LTD (KR) | 2025-08-27 | — | — | EP | disclosed |
| US-12371516-B2 | Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-12264232-B2 | Modified high-cis polybutadiene polymer, related methods and tire components | BRIDGESTONE CORPORATION (JP) | 2025-04-01 | — | — | US | disclosed |
| US-20250066516-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | BRIDGESTONE CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| US-12209149-B2 | Continuous preparation system of conjugated diene-based polymer | LG CHEM, LTD. (KR) | 2025-01-28 | — | — | US | disclosed |
| US-7008899-B2 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2006-03-07 | — | — | US | disclosed |
| WO-2005061563-A1 | BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2005-07-07 | — | — | WO | disclosed |
| US-20050131174-A1 | Bulk polymerization process for producing polydienes | BRIDGESTONE CORP. | 2005-06-16 | — | — | US | disclosed |
| US-6897270-B2 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20050038215-A1 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2005-02-17 | — | — | US | disclosed |
| US-20040116638-A1 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| US-6699813-B2 | COMPOSITION THAT IS COMBINATION OF OR REACTION PRODUCT OF LANTHANIDE COMPOUND, ALKYLATING AGENT, NICKEL-CONTAINING COMPOUND, AND OPTIONALLY HALOGEN-CONTAINING COMPOUND THAT INCLUDES ONE OR MORE LABILE HALOGEN ATOMS | BRIDGESTONE CORPORATION (JP) | 2004-03-02 | — | — | US | disclosed |
| EP-1370593-A1 | CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM | Bridgestone Corporation (JP) | 2003-12-17 | — | — | EP | disclosed |
| US-20030176276-A1 | Lanthanide-based catalyst composition for the manufacture of polydienes | BRIDGESTONE CORPORATION (JP) | 2003-09-18 | — | — | US | disclosed |
| WO-2002068484-A1 | CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM | BRIDGESTONE CORPORATION (JP) | 2002-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565546-B2 | Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer | CARM1, RIF1, UFM1 | TP53 3513/4885P2RX4 4153/4885P2RX1 4167/4885 |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | MALT1, INO80C, RTCB | TP53 1831/4885P2RX4 4823/4885P2RX1 4731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.